Skip to main content Skip to main navigation menu Skip to site footer

Acute kidney injury in a covid-19 patient with Non-ST elevation myocardial infarction: case report


Introduction: Coronavirus disease 2019 (COVID-19) has a variety of manifestations, from asymptomatic to acute illness that can affect several organs, although being primarily associated with the respiratory system. The virus binds to angiotensin-converting enzyme-2 (ACE-2) receptors in humans and the expression of ACE-2 in heart and kidneys explains the association of COVID-19 with the renal and cardiovascular systems.

Case description: Male, 62-year-old, was admitted to the emergency room (ER) for presented shortness of breath, angina pain, and gastric pain. He was a smoker and denied having comorbidities. At arrival, an examination of vital signs and physical showed tachypnea, tachycardia, hypertension, and bilateral crackles. The electrocardiography (ECG) showed left ventricular hypertrophy and Non-ST-Elevation in anterolateral. The chest x-ray showed pneumonia and cardiomegaly. Laboratory findings showed that decreased renal function and Polymerase Chain Reaction (PCR) test was positive, and increased in serum Troponin level supported the diagnosis of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2) pneumonia with Non-ST elevation myocardial infarct (NSTEMI) and Acute Kidney Injury (AKI). Loading of Aspilet, Clopidogrel, Atorvastatin, and Thrombolysis with Fondaparinux was done. The following day, transthoracic echocardiography was performed anterolateral regional wall motion abnormality with 43% of Left Ventricle Ejection Fraction (LVEF). Two weeks after hospital discharge, the echocardiography evaluation showed no improvement and was diagnosed with Chronic Heart Failure with New York Heart Association (NYHA) Functional Classification II et causa Coronary Artery Disease.

Conclusion: Treatment of covid-19 patients with cardiovascular and renal complications is quite challenging since there is no specific guideline for COVID-19 patients with renal and cardiovascular complications.


  1. Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328-333. doi:10.1016/
  2. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
  3. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi:10.1016/j.kint.2020.03.005
  4. Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151-160. doi:10.1681/ASN.2020050615
  5. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905-919. doi:10.1007/s10096-020-04138-6
  6. Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020;126(10):1456-1474. doi:10.1161/CIRCRESAHA.120.317015
  7. Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Malakan Rad E. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J. 2020;72(1):41-49. doi:10.1186/s43044-020-00075-z
  8. You H, Zhao Q, Dong M. The Key Genes Underlying Pathophysiology Correlation Between the Acute Myocardial Infarction and COVID-19. Int J Gen Med. 2022;15:2479-2490. doi:10.2147/IJGM.S354885
  9. Wolsky RM, Bateman CT. A Myocardial Infarction Following a Mild Case of COVID-19 in a 26-Year-Old Male. Cureus. 2022;14(7):e27026. doi:10.7759/cureus.27026
  10. Othman F, Abid AR, Alibrahim M, et al. Non-ST Segment Elevation Myocardial Infarction in a Patient with COVID-19. HEART VIEWS. 2020;21(3):5-12.
  11. Watson RA, Johnson DM, Dharia RN, Merli GJ, Doherty JU. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system. Hosp Pract. 2020;48(4):169-179. doi:10.1080/21548331.2020.1772639
  12. Walsh MN, Sorgente A, Fischman DL, Bates ER, Grapsa J. The COVID-19 Pandemic and Cardiovascular Complications. JACC Case Rep. 2020;2(9):1235-1239. doi:10.1016/j.jaccas.2020.06.017
  13. Diebold M, Zimmermann T, Dickenmann M, et al. Comparison of Acute Kidney Injury in Patients with COVID-19 and Other Respiratory Infections: A Prospective Cohort Study. J Clin Med. 2021;10(11):2288-2296. doi:10.3390/jcm10112288
  14. Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213-221. doi:10.1159/000507305
  15. Legrand M, Bell S, Forni L, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751-764. doi:10.1038/s41581-021-00452-0
  16. Głowacka M, Lipka S, Młynarska E, Franczyk B, Rysz J. Acute Kidney Injury in COVID-19. Int J Mol Sci. 2021;22(15):8081-8096. doi:10.3390/ijms22158081
  17. Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67(2):698-705. doi:10.1111/j.1523-1755.2005.67130.x
  18. Chávez-Valencia V, Orizaga-de-la-Cruz C, Lagunas-Rangel FA. Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality. Diseases. 2022;10(3):53-62. doi:10.3390/diseases10030053
  19. Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17(1):109-117. doi:10.1186/s12882-016-0323-6
  20. Jonny, Violetta L, Kartasasmita AS, Amirullah Roesli RM, Rita C. Pharmacological Treatment Options for Coronavirus Disease-19 in Renal Patients. Uribarri J, ed. Int J Nephrol. 2021;2021:1-9. doi:10.1155/2021/4078713
  21. Wong CKH, Au ICH, Cheng WY, et al. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID ‐19: a self‐controlled case series study. Aliment Pharmacol Ther. 2022;56(1):121-130. doi:10.1111/apt.16894
  22. Setiati S, Azwar MK. COVID-19 and Indonesia. Acta Med Indones. 2020;52(1):84-89.
  23. Mohamadi Yarijani Z, Najafi H. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study. Biomed Pharmacother. 2021;142:111966. doi:10.1016/j.biopha.2021.111966
  24. Olson G, Davis AM. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA. 2020;323(9):885-892. doi:10.1001/jama.2019.21118
  25. Wiersinga WJ, Bonten MJ, Boersma WG, et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med. 2018;76(1):10-18.

How to Cite

Rihi Pake, I. A. ., Putri, P. E. D., Suwirya, A. P. ., & Lestari, D. N. D. (2023). Acute kidney injury in a covid-19 patient with Non-ST elevation myocardial infarction: case report. Intisari Sains Medis, 14(1), 270–274.




Search Panel

Indry Agatha Rihi Pake
Google Scholar
ISM Journal

Putu Eka Dianti Putri
Google Scholar
ISM Journal

Agung Pradnyana Suwirya
Google Scholar
ISM Journal

Desak Nyoman Desy Lestari
Google Scholar
ISM Journal